Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 15 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
REVA CLINICS from Leuven, company number BE0802866822, closed financial year 2025 with a result of € -14,828 after tax. For that financial year REVA CLINICS recorded a gross margin of € -10,000 and equity of € -22,735. Compared with financial year 2024, the result moved from € -12,098 to € -14,828. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ -22,735
▼ € 14,828 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -14,828
▼ 23 % more loss than in 2024
Profit after tax over the fiscal year.
€ 73
▼ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -27,735.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 25,541
▲ 66% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,538
▲ € 7,333 vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 462 | € -10,300 | € -10,000 | ▲ € 300 |
| Profit after taxes | € -809 | € -12,098 | € -14,828 | ▼ € 2,730 |
| Equity | € 4,191 | € -7,907 | € -22,735 | ▼ € 14,828 |
| Total debts | € 3,058 | € 39,106 | € 73,736 | ▲ 89% |
| Cash | € 1,692 | € 256 | € 73 | ▼ 72% |
| Retained profit | € -809 | € -12,907 | € -27,735 | ▼ € 14,828 |
| Balance sheet total | € 7,249 | € 31,199 | € 51,001 | ▲ 63% |
Key figures of REVA CLINICS, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to REVA CLINICS?
What happened at REVA CLINICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 14,828. filed late Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 809 loss in 2023 to € 14,828 loss in 2025.
A new publication or filing at REVA CLINICS? We notify you, reason included.
Follow REVA CLINICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of JAFEMA, KOUTERLOS INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
REVA CLINICSBehind REVA CLINICS is Reza Niknejad Hamid. The shares are held by JAFEMA (80%) and KOUTERLOS INVEST (20%).
Directors
According to the 2025 annual accounts
Shareholders
80%
20%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Tervuursesteenweg 198
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Google Workspace
Hosting
GOOGLE-CLOUD-PLATFORM - Google LLC, US
DNS
TransIP DNS
Website info
Features
Security
Details
- Company number
- 0802.866.822
- VAT number
- BE 0802.866.822
- Registered office
- Tervuursesteenweg 198, 3001 Leuven
- Names & denominations
- REVA CLINICS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 June 2023
- Peppol
- Active · Active since 20 Feb 2026
- Contact
- revaclinics.be
- Activities · NACE
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Overige zakelijke dienstverlening, neg